STACEY KING: Open Payments
NPI 1598146631 · ROBERTSDALE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$140 in 7 payments from 6 companies in 2025. Trend: 2023 $838 · 2024 $624 · 2025 $140
Food & beverage: $140
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Corium, LLC | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Kerendia, MOUNJARO, Azstarys, JARDIANCE, FARXIGA, Ozempic, TRELEGY ELLIPTA.
Industry payments across AL — which companies pay providers there.
